Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H23N2S2.I |
Molecular Weight | 518.477 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[I-].CCN1C(SC2=C1C=CC=C2)=CC=CC=CC3=[N+](CC)C4=C(S3)C=CC=C4
InChI
InChIKey=MNQDKWZEUULFPX-UHFFFAOYSA-M
InChI=1S/C23H23N2S2.HI/c1-3-24-18-12-8-10-14-20(18)26-22(24)16-6-5-7-17-23-25(4-2)19-13-9-11-15-21(19)27-23;/h5-17H,3-4H2,1-2H3;1H/q+1;/p-1
Molecular Formula | HI |
Molecular Weight | 127.9124 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C23H23N2S2 |
Molecular Weight | 391.572 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Optical Activity | NONE |
Dithiazanine, 3-ethyl-2-[5-(3-ethyl-2-benzothiazolinylidene)-l, 3-
pentadienyl] benzothiazolium iodide, is an old effective broad-spectrum human anthelmintic. In proper dosage, this polyvermicide is therapeutic for trichuriasis, strongyloidiasis, ascariasis, and enterobiasis. The drug also has significant anthelmintic
activity against human hookworm, Necator americanus.
It fulfills a need for an effective therapeutic
for trichuriasis and strongyloidiasis. Dithiazanine is
useful for the treatment of patients with either
single or multiple intestinal helminth infections. It
is effective for mass therapy for trichuriasis. Nowdays Dithiazanine is used only as a veterinary anthelmintic for dogs. It has being proved to be a highly toxic chemical, with a lethal dose for humans of about 4–16 mg/kg by oral ingestion.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Trichuris Trichiura |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Dithiazanine iodide Approved UseUse for treating dogs for large
roundworms, hookworms, whipworms,
and strongyloides |
|||
Curative | Delvex Approved UseHelminth (worm) infections |
Doses
Dose | Population | Adverse events |
---|---|---|
300 mg 3 times / day multiple, oral Highest studied dose Dose: 300 mg, 3 times / day Route: oral Route: multiple Dose: 300 mg, 3 times / day Sources: |
unhealthy n = 73 Health Status: unhealthy Condition: Helminthiasis Sex: M+F Population Size: 73 Sources: |
Disc. AE: Nausea... AEs leading to discontinuation/dose reduction: Nausea (1.37%) Sources: |
200 mg 3 times / day multiple, oral Studied dose Dose: 200 mg, 3 times / day Route: oral Route: multiple Dose: 200 mg, 3 times / day Sources: |
unhealthy n = 35 Health Status: unhealthy Condition: Helminthiasis Population Size: 35 Sources: |
Disc. AE: Vomiting... AEs leading to discontinuation/dose reduction: Vomiting (severe, 11.43%) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Nausea | 1.37% Disc. AE |
300 mg 3 times / day multiple, oral Highest studied dose Dose: 300 mg, 3 times / day Route: oral Route: multiple Dose: 300 mg, 3 times / day Sources: |
unhealthy n = 73 Health Status: unhealthy Condition: Helminthiasis Sex: M+F Population Size: 73 Sources: |
Vomiting | severe, 11.43% Disc. AE |
200 mg 3 times / day multiple, oral Studied dose Dose: 200 mg, 3 times / day Route: oral Route: multiple Dose: 200 mg, 3 times / day Sources: |
unhealthy n = 35 Health Status: unhealthy Condition: Helminthiasis Population Size: 35 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Dithiazanine, an effective broad-spectrum anthelmintic; results of therapy of trichuriasis, strongyloidiasis, enterobiasis, ascariasis, and hookworm infection. | 1957 Dec 21 |
|
[In Vitro Activities Of Various Drugs Against Adult Worms Of Clonorchis Sinensis]. | 1980 Dec |
|
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. | 2013 Jul 16 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13480859
Trichuriasis in 164 patients was treated with doses of 200 mg. thrice daily; this dosage, continued for five days, cured 97% of the patients. Ascariasis was treated in 42 persons with up to 600 mg. daily in divided doses. There was a 97% reduction in the egg-count of these patients, and 28 of them showed complete elimination of the infection. Strongyloidiasis was eliminated in 16 out of a group of 18 patients treated for 5 to 21 days. Enterobiasis was treated in 35 boys under conditions showing that 100 mg. of dithiazanine thrice daily for five days sufficed for cure in all cases.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12902729
Moderate in vitro activity against adult worms of Clororchis sinensis was observed in the concentrations of 1.0 and 0.1 ug/ml of gentian dithiazanine.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:54:55 GMT 2023
by
admin
on
Sat Dec 16 16:54:55 GMT 2023
|
Record UNII |
8OEC3RA07X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.763C
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6390
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
C75216
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
10578
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
228275
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
SUB06331MIG
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
100000081838
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
208-186-7
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
8OEC3RA07X
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
768
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
514-73-8
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL1185568
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
221154
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
Dithiazanine iodide
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
m4682
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
DBSALT001680
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
DTXSID8022955
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |